BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 3rd Quarter - Termination (No Activity)

ALVOGEN

via EAST END GROUP, LLC

3rd Quarter (July 1 - Sep 30) · 2026Posted Jul 15, 2026Filing document ↗LDA record ↗

Income$45Kfee reported

Client

Name: ALVOGEN
Description: Pharmaceutical company developing and manufacturing generic, brand and biosimilar products
Location: New Jersey · United States of America

Registrant

Firm: EAST END GROUP, LLC
Description: Consulting and government affairs.
Location: Chevy Chase, Maryland, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

ALVOGEN — Lobbying — Receipts Report